DASH vs MXCT · P/E 76, rev $13.72B vs rev $38.6M
DoorDash, Inc. Class A Common Stock (DASH) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the DASH and MXCT stock pages for the full models.
Not investment advice.